These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35191751)

  • 1. GeneTargeter: Automated
    Cárdenas P; Esherick LY; Chambonnier G; Dey S; Turlo CV; Nasamu AS; Niles JC
    CRISPR J; 2022 Feb; 5(1):155-164. PubMed ID: 35191751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum.
    Kudyba HM; Cobb DW; Florentin A; Krakowiak M; Muralidharan V
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30295650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 Editing of the Plasmodium falciparum Genome.
    Adjalley S; Lee MCS
    Methods Mol Biol; 2022; 2470():221-239. PubMed ID: 35881349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid-free CRISPR/Cas9 genome editing in Plasmodium falciparum confirms mutations conferring resistance to the dihydroisoquinolone clinical candidate SJ733.
    Crawford ED; Quan J; Horst JA; Ebert D; Wu W; DeRisi JL
    PLoS One; 2017; 12(5):e0178163. PubMed ID: 28542423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Heterochromatin Protein 1 Function in the Malaria Parasite Plasmodium falciparum Using a Conditional Domain Deletion and Swapping Approach.
    Bui HTN; Passecker A; Brancucci NMB; Voss TS
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guide RNA selection for CRISPR-Cas9 transfections in Plasmodium falciparum.
    Ribeiro JM; Garriga M; Potchen N; Crater AK; Gupta A; Ito D; Desai SA
    Int J Parasitol; 2018 Sep; 48(11):825-832. PubMed ID: 29906414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Collation of the Plasmodium falciparum WDR Protein Superfamily Reveals Malarial Parasite-Specific Features.
    Chahar P; Kaushik M; Gill SS; Gakhar SK; Gopalan N; Datt M; Sharma A; Gill R
    PLoS One; 2015; 10(6):e0128507. PubMed ID: 26043001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of CRISPR/Cas System for Improving Genome Editing Efficiency in
    Zhao Y; Wang F; Wang C; Zhang X; Jiang C; Ding F; Shen L; Zhang Q
    Front Microbiol; 2020; 11():625862. PubMed ID: 33488567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 and genetic screens in malaria parasites: small genomes, big impact.
    Ishizaki T; Hernandez S; Paoletta MS; Sanderson T; Bushell ESC
    Biochem Soc Trans; 2022 Jun; 50(3):1069-1079. PubMed ID: 35621119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic editing by CRISPR/dCas9 in
    Xiao B; Yin S; Hu Y; Sun M; Wei J; Huang Z; Wen Y; Dai X; Chen H; Mu J; Cui L; Jiang L
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):255-260. PubMed ID: 30584102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 knockouts reveal genetic interaction between strain-transcendent erythrocyte determinants of
    Kanjee U; Grüring C; Chaand M; Lin KM; Egan E; Manzo J; Jones PL; Yu T; Barker R; Weekes MP; Duraisingh MT
    Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9356-E9365. PubMed ID: 29078358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tagging to endogenous genes of Plasmodium falciparum using CRISPR/Cas9.
    Kuang D; Qiao J; Li Z; Wang W; Xia H; Jiang L; Dai J; Fang Q; Dai X
    Parasit Vectors; 2017 Dec; 10(1):595. PubMed ID: 29197418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient CRISPR/Cas9 system in Plasmodium falciparum using Cas9-expressing parasites and a linear donor template.
    Nishi T; Shinzawa N; Yuda M; Iwanaga S
    Sci Rep; 2021 Sep; 11(1):18501. PubMed ID: 34531479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum In Vitro Drug Resistance Selections and Gene Editing.
    Ng CL; Fidock DA
    Methods Mol Biol; 2019; 2013():123-140. PubMed ID: 31267498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 Editing of the Plasmodium falciparum Genome: Special Applications.
    Zhang X; Deitsch KW; Dzikowski R
    Methods Mol Biol; 2022; 2470():241-253. PubMed ID: 35881350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum.
    Pritam M; Singh G; Swaroop S; Singh AK; Singh SP
    BMC Bioinformatics; 2019 Feb; 19(Suppl 13):468. PubMed ID: 30717656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 system in Plasmodium falciparum using the centromere plasmid.
    Payungwoung T; Shinzawa N; Hino A; Nishi T; Murata Y; Yuda M; Iwanaga S
    Parasitol Int; 2018 Oct; 67(5):605-608. PubMed ID: 29886342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome content analysis yields new insights into the relationship between the human malaria parasite Plasmodium falciparum and its anopheline vectors.
    Oppenheim SJ; Rosenfeld JA; DeSalle R
    BMC Genomics; 2017 Feb; 18(1):205. PubMed ID: 28241792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse target gene modifications in Plasmodium falciparum using Bxb1 integrase and an intronic attB.
    Balabaskaran-Nina P; Desai SA
    Parasit Vectors; 2018 Oct; 11(1):548. PubMed ID: 30333047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 Genome Editing Reveals That the Intron Is Not Essential for
    Bryant JM; Regnault C; Scheidig-Benatar C; Baumgarten S; Guizetti J; Scherf A
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.